Angiotensin-converting enzyme inhibition or mineralocorticoid receptor blockade do not affect prevalence of atrial fibrillation in patients undergoing cardiac surgery.
| Autor: | Pretorius M, Murray KT, Yu C, Byrne JG, Billings FT 4th, Petracek MR, Greelish JP, Hoff SJ, Ball SK, Mishra V, Body SC, Brown NJ, Pretorius, Mias, Murray, Katherine T, Yu, Chang, Byrne, John G, Billings, Frederic T 4th, Petracek, Michael R, Greelish, James P, Hoff, Steven J |
|---|---|
| Zdroj: | Critical Care Medicine; Oct2012, Vol. 40 Issue 10, p2805-2812, 8p |
| Databáze: | Complementary Index |
| Externí odkaz: |
|